Psychological Impact of Pregnancy of Unknown Location
SOUL
1 other identifier
observational
150
1 country
1
Brief Summary
To assess the psychological impact of pregnancy of unknown location (PUL) classification pending a final diagnosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 2, 2020
CompletedFirst Submitted
Initial submission to the registry
February 1, 2021
CompletedFirst Posted
Study publicly available on registry
February 5, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2022
CompletedResults Posted
Study results publicly available
January 15, 2025
CompletedJanuary 15, 2025
January 1, 2025
1.3 years
February 1, 2021
March 15, 2024
January 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Psychological Morbidity
Psychological morbidity will be assessed using the Hospital Anxiety and Depression Scale on time of PUL classification, 48 hours from PUL classification and following final diagnosis and management. For both Anxiety and Depression, participants can score anywhere from 0 to 21. Score of 11 and above indicate moderate to severe anxiety and depression.
0 hours, 48 hours and point of diagnosis (within 2 wees)
Study Arms (2)
Patient: point of care (POC) result not shared
Patients in this phase of the study will not be provided with the POC BhCG result. They will await the laboratory result. Simultaneously we will ascertain reliability of POC in clinical practice during this time.
Patient: point of care (POC) result shared
Patients in this phase will be informed of the POC test result, which will reduce the time to which they receive the result. Prior to transfer to this phase, correlation between POC and laboratory BhCG levels will be calculated in order to confirm its reliability by creating a correlation curve using the data.
Interventions
Patients and partners will be asked to complete the questionnaire at three time points: 1) On classification of PUL at time zero once blood is taken, 2) at the 48-hour time point after blood is taken (if 48 hour bloods are required for the patient); and 3) after definitive diagnosis and management.
Patients will have 1ml sample of blood taken for POCT at two time points: 1) On classification of PUL at time zero at the same time as when routine blood samples taken; and 2) at the 48-hour time point at the same time as when routine blood samples are taken (if 48 hour bloods are required).
Eligibility Criteria
Pregnant women attending the Early Pregnancy Unit in the first trimester (up to 14 weeks gestation) with a pregnancy of unknown who are over 18 years old and are able to give consent.
You may qualify if:
- Pregnant women attending the Early Pregnancy Unit in the first trimester (up to 14 weeks gestation) with a pregnancy of unknown who are over 18 years old and are able to give consent.
You may not qualify if:
- Presence diagnosed with cancer
- The presence of an acute medical condition
- Patients/partners aged less than 18 years
- Patients or partners who cannot give fully informed study consent (language or learning impairment)
- Presence of a viable intrauterine pregnancy, ectopic pregnancy and miscarriage.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Imperial College Londonlead
- Imperial College Healthcare NHS Trustcollaborator
Study Sites (1)
Imperial College Healthcare NHS Trust
London, W12 0HS, United Kingdom
Related Publications (1)
Kyriacou C, Yang W, Kapur S, Maheetharan S, Pikovsky M, Parker N, Barcroft J, Bobdiwala S, Sur S, Stalder C, Gould D, Ofili-Yebovi D, Day A, Unsworth N, Wilkes EH, Tan T, Bourne T. Ambulatory human chorionic gonadotrophin (hCG) testing: a verification of two hCG point of care devices. Clin Chem Lab Med. 2023 Oct 30;62(4):664-673. doi: 10.1515/cclm-2023-0703. Print 2024 Mar 25.
PMID: 37886834DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr Margaret Pikovsky
- Organization
- Imperial College Healthcare NHS Trust
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 1, 2021
First Posted
February 5, 2021
Study Start
December 2, 2020
Primary Completion
March 31, 2022
Study Completion
March 31, 2022
Last Updated
January 15, 2025
Results First Posted
January 15, 2025
Record last verified: 2025-01